Antigen presentation by cisplatin‐activated macrophages: Role of soluble factor(s) and second messengers
- 1 December 1998
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 76 (6), 513-519
- https://doi.org/10.1046/j.1440-1711.1998.00769.x
Abstract
Cisplatin [cis-dichlorodiammine platinum (II)], a potent anti-tumour compound, stimulates immune responses by activating macrophages and other cells of the immune system. The mechanism by which cisplatin activates these cells is poorly characterized. Present investigations were undertaken to study the mechanism of antigen presentation by cisplatin-treated macrophages. Cisplatin-treated macrophages showed a biphasic pattern of antigen presentation to keyhole limpet haemocyanin (KLH)-primed T cells. The second phase of antigen presentation was not due to the continuous presence of cisplatin in the culture medium; rather, it was induced by soluble factors released by cisplatin-treated macrophages. Co-incubation of macrophages with cisplatin and inhibitor of serine/threonine or protein tyrosine phosphatase resulted in an augmentation of cisplatin-induced antigen presentation. In contrast, treatment of macrophages with cisplatin and inhibitor of protein kinase C or protein tyrosine kinase inhibited cisplatin-induced antigen presentation. These observations suggest that antigen presentation by cisplatin-treated macrophages is regulated by reversible action of protein phosphatases and kinases. The antigen-presenting ability of cisplatin-treated macrophages was also inhibited by EGTA, nifedipine, TMB-8, W-7 and calmidazolium, suggesting the probable involvement of Ca2+, calmodulin and calmodulin-dependent kinases in this process.Keywords
Funding Information
- University Grants Commission
This publication has 29 references indexed in Scilit:
- Mechanism of NF-κB translocation in macrophages treated in vitro with cisplatinImmunology Letters, 1998
- LFA‐1‐dependent tumoricidal activity of cisplatin‐treated macrophagesImmunology & Cell Biology, 1998
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Role of calcium and calmodulin in the activation of murine peritoneal macrophages with cisplatinInternational Journal of Immunopharmacology, 1994
- Antigen Presentation by Major Histocompatibility Complex Class I-B MoleculesAnnual Review of Immunology, 1994
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- In vitro activation of rGM‐CSF derived bone marrow macrophages by cisplatin and lipopolysaccharideImmunology & Cell Biology, 1991
- The Basis for the Immunoregulatory Role of Macrophages and Other Accessory CellsScience, 1987
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Interleukin l and T Cell ActivationImmunological Reviews, 1982